Skip to main content
SpringerLink
Log in

Glutamatergic compounds: a perspective

  • Chapter
Drugs for Relapse Prevention of Alcoholism

Part of the book series: Milestones in Drug Therapy MDT ((MDT))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tsai G, Gastfriend DR, Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152(3): 332–340

    PubMed  CAS  Google Scholar 

  2. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49: 173–184

    PubMed  CAS  Google Scholar 

  3. Krystal JH, Petrakis IL, Mason G, Trevisan L, D’Souza DC (2003) N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 99: 79–94

    Article  PubMed  CAS  Google Scholar 

  4. Johnson TD (1996) Modulation of channel function by polyamines. Trends Pharmacol Sci 17(1): 22–27

    Article  PubMed  CAS  Google Scholar 

  5. Parsons CG, Danysz W, Lodge D (2002) Introduction to glutamate receptors, their function and pharmacology. In: D Lodge, W Danysz, CG Parsons (eds): Ionotropic glutamate receptors as therapeutic targets. FP Graham Publishing Co., Johnson City,TN, 1–27

    Google Scholar 

  6. Spanagel R, Bienkowski P (2002) Glutamatergic mechanisms in alcohol dependence and addiction. In: D Lodge, W Danysz, CG Parsons (eds): Therapeutic Potential of Ionotropic Glutamate Receptor Antagonists and Modulators. Graham Publishing Co., Johnson City, TN, USA, 375–403

    Google Scholar 

  7. Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243(4899): 1721–1724

    PubMed  CAS  Google Scholar 

  8. Ren H, Honse Y, Peoples RW (2003) A site of alcohol-action in the fourth membrane-associated domain of the n-methyl-d-aspartate receptor. J Biol Chem 278(49): 48815–48820

    Article  PubMed  CAS  Google Scholar 

  9. Rassnick S, Pulvirenti L, Koob GF (1992) Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology 109(1–2): 92–98

    PubMed  CAS  Google Scholar 

  10. Shelton KL, Balster RL (1997) Effects of gamma-aminobutyric acid agonists and N-methyl-Daspartate antagonists on a multiple schedule of ethanol and saccharin self-administration in rats. J Pharmacol Exp Ther 280(3): 1250–1260

    PubMed  CAS  Google Scholar 

  11. Danysz W, Dyr W, Jankowska E, Glazewski S, Kostowski W (1992) The involvement of NMDA receptors in acute and chronic effects of alcohol. Alcohol Clin Exp Res 16: 499–504

    PubMed  CAS  Google Scholar 

  12. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-Daspartate (NMDA) receptor antagonist — a review of preclinical data. Neuropharmacology 38: 735–767

    PubMed  CAS  Google Scholar 

  13. Hölter SM, Danysz W, Spanagel R (1996) Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 314: R1–R2

    PubMed  Google Scholar 

  14. Piasecki J, Koros E, Dyr W, Kostowski W, Danysz W, Bienkowski P (1998) Ethanol-reinforced behavior in the rat: effects of uncompetitive NMDA receptor antagonist, memantine. Eur J Pharmacol 354(2–3): 135–143

    PubMed  CAS  Google Scholar 

  15. Parsons CG, Danysz W, Quack G (2000) Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists — in vitro characterisation. Amino Acids 19: 157–166

    Article  PubMed  CAS  Google Scholar 

  16. Bienkowski P, Krzascik P, Koros E, Kostowski W, Scinska A, Danysz W (2001) Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in rat. Eur J Pharmacol 413: 81–89

    Article  PubMed  CAS  Google Scholar 

  17. Bienkowski P, Koros E, Kostowski W, Danysz W (1999) Effects of N-methyl-D-aspartate receptor antagonists on reinforced and non-reinforced responding for ethanol in rats. Alcohol 18: 131–137

    Article  PubMed  CAS  Google Scholar 

  18. Hölter SM, Danysz W, Spanagel R (2000) Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. J Pharmacol Exp Ther 292(2): 545–552

    PubMed  Google Scholar 

  19. Vengeliene V, Bachteler D, Danysz W, Spanagel R (2005) The role of the NMDA receptor complex in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect. J Neuropharmacology; in press

    Google Scholar 

  20. Bachteler D, Economidou D, Danysz W, Ciccocioppo R, Spanagel R (2005) The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology; in press

    Google Scholar 

  21. Böckström P, Hyytiä P (2004) Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol Clin Exp Res 28(4): 558–565

    Google Scholar 

  22. Hundt W, Danysz W, Hölter SM, Spanagel R (1998) Ethanol and N-methyl-D-aspartate receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology 135: 44–51

    Article  PubMed  CAS  Google Scholar 

  23. Colombo G, Grant KA (1992) NMDA receptor complex antagonists have ethanol-like discriminative stimulus effects. Ann N Y Acad Sci 654: 421–423

    PubMed  CAS  Google Scholar 

  24. Malenka RC (2003) Synaptic plasticity and AMPA receptor trafficking. Ann N Y Acad Sci 1003: 1–1

    Article  PubMed  CAS  Google Scholar 

  25. Luscher C, Xia H, Beattie EC, Carroll RC, von Zastrow M, Malenka RC, Nicoll RA (1999) Role of AMPA receptor cycling in synaptic transmission and plasticity. Neuron 24: 649–658

    Article  PubMed  CAS  Google Scholar 

  26. Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A, Kaiser KM, Koster HJ, Borchardt T, Worley P et al. (1999) Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 284(5421): 1805–1811

    Article  PubMed  CAS  Google Scholar 

  27. Lu L, Grimm JW, Shaham Y, Hope BT (2003) Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem 85: 1604–1613

    Article  PubMed  CAS  Google Scholar 

  28. Sutton MA, Schmidt EF, Choi KH, Schad CA, Whisler K, Simmons D, Karanian DA, Monteggia LM, Neve RL, Self DW (2003) Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 421(6918): 70–75

    Article  PubMed  CAS  Google Scholar 

  29. Brückner MK, Rossner S, Arendt T (1997) Differential changes in the expression of AMPA receptors genes in rat brain after chronic exposure to ethanol: an in situ hybridization study. J Hirnforsch 38(3): 369–376

    PubMed  Google Scholar 

  30. Cowen MS, Schroff KC, Gass P, Sprengel R, Spanagel R (2003) Neurobehavioral effects of alcohol in AMPA receptor subunit (GluR1) deficient mice. Neuropharmacology 45: 325–333

    Article  PubMed  CAS  Google Scholar 

  31. Sanchis-Segura C, Vengeliene V, Zghoul T, Bachteler D, Gass P, Sprengel R, Spanagel R (2004) Involvement of AMPA receptor GluR-C subunit in alcohol relapse. Alcohol Clin Exp Res 285: 54A

    Google Scholar 

  32. Stephens DN, Brown G (1999) Disruption of operant oral selfadministration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI66. Alcohol Clin Exp Res 23: 1914–1920

    PubMed  CAS  Google Scholar 

  33. Conn P, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37: 205–237

    Article  PubMed  CAS  Google Scholar 

  34. Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R (2003) Insight into the function of group I and group II metabotropic glutamate (mGlu) receptors: behavioral characterization and implications for the treatment of CNS disorders. Behav Pharmacol 14: 257–277

    PubMed  CAS  Google Scholar 

  35. Spooren W, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C (2000) Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in rodents. J Pharmacol Exp Ther 295: 1267–1275

    PubMed  CAS  Google Scholar 

  36. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R, Pilc A (2001) Potential anxiolytic-and anti-depressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132: 1423–1430

    Article  PubMed  CAS  Google Scholar 

  37. Schulz B, Fendt M, Gasparini F, Lingenhohl K, Kuhn R, Koch M (2001) The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology 41: 1–7

    Article  PubMed  CAS  Google Scholar 

  38. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neurosci 4: 873–874

    Article  PubMed  CAS  Google Scholar 

  39. Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167: 257–264

    PubMed  CAS  Google Scholar 

  40. McGeehan AJ, Olive MF (2003) The anti-relapse compound acamprosate inhibits the development of a conditioned preference to ethanol and cocaine but not morphine. Br J Pharmacol 138: 9–12

    Article  PubMed  CAS  Google Scholar 

  41. Sharko AC, Kimberly I, Koenig H, Lau K, Ou CJ, Olive MF, Camarini R, Hodge CW (2002) Involvement of metabotropic glutamate receptor subtype 5 (mGluR5) in alcohol self-administration. Alcohol Clin Exp Res 26: 112A

    Google Scholar 

  42. Bäckström P, Bachteler D, Koch S, Hyytiä P, Spanagel R (2004) mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29: 921–928

    PubMed  Google Scholar 

  43. Sorensen SD, Conn PJ (2003) G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression. Neuropharmacology 44: 699–706

    Article  PubMed  CAS  Google Scholar 

  44. Kotecha SA, Jackson MF, Al-Mahrouki AA, Roder JC, Orser BA, MacDonald JF (2003) Co-stimulation of mGluR5 and NMDA receptors is required for potentiation of excitatory synaptic transmission in hippocampal neurons. J Biol Chem 278: 27742–27749

    Article  PubMed  CAS  Google Scholar 

  45. Hermans E, Challiss RA (2001) Structural, signaling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem J 359: 465–484

    Article  PubMed  CAS  Google Scholar 

  46. Schoepp DD, Conn PJ (1993) Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 14: 13–20

    Article  PubMed  CAS  Google Scholar 

  47. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura, Magnone MC, Lascorz J, Depne M, Holzberg D, Soyka M et al. (2004) The circadian clock gene Period2 alters the glutamatergic system and thereby modulates alcohol consumption. Nature Med; in press

    Google Scholar 

  48. Spanagel R, Siegmund S, Cowen M, Schroff KC, Schumann G, Fiserova M, Sillaber I, Wellek S, Singer M, Putzke J (2002) The neuronal nitric oxide synthase gene is critically involved in neurobehavioral effects of alcohol. J Neurosci 22(19): 8676–8683

    PubMed  CAS  Google Scholar 

  49. Werner C, Raivich G, Cowen M, Strekalova T, Sillaber I, Spanagel R, Hofmann F (2004) Importance of NO/cGMP signaling via cGMP-dependent protein kinase II for mediating emotionality and neurobehavioral effects of alcohol. Eur J Neurosci; in press

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Central Institute of Mental Health, Department of Psychopharmacology, University of Heidelberg, (CIMH), J5, 68159, Mannheim, Germany

    Daniel Bachteler & Rainer Spanagel

Authors
  1. Daniel Bachteler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rainer Spanagel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Psychopharmakologie, Universit ät Heidelberg, J5, Zentralinstitut für Seelische Gesundheit, 68159, Mannheim, Germany

    Rainer Spanagel

  2. Klinik für Abhängiges Verhalten und Suchtmedizin, J5, Zentralinstitut für Seelische Gesundheit, 68159, Mannheim, Germany

    Karl F. Mann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Bachteler, D., Spanagel, R. (2005). Glutamatergic compounds: a perspective. In: Spanagel, R., Mann, K.F. (eds) Drugs for Relapse Prevention of Alcoholism. Milestones in Drug Therapy MDT. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7305-9_19

Download citation

Publish with us

Policies and ethics

Search

Navigation